Labcorp Holdings vs Roivant Sciences
Labcorp Holdings (LH), health care, and Roivant Sciences (ROIV), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Labcorp Holdings is worth $29.9B on the stock market and Roivant Sciences $28B: Labcorp Holdings is valued at 7% more. Labcorp Holdings's operating margin in its latest fiscal year was 9.92% and Roivant Sciences's -6236%. Over the past year Labcorp Holdings's share price has moved +43.4% and Roivant Sciences's +88.2%.
Key facts
- Labcorp Holdings market value
- $29.9B
- Roivant Sciences market value
- $28B
- Labcorp Holdings P/E
- 30.2
- Labcorp Holdings revenue
- $14BFY to 2025-12-31
- Roivant Sciences revenue
- $8.3MFY to 2026-03-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Labcorp Holdings | Roivant Sciences |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2026-03-31 |
| Size | ||
| Market cap | $29.9Bhigher | $28Blower |
| Revenue | $14Bhigher | $8.3Mlower |
| Earnings | $876.5Mhigher | -$299.8Mlower |
| Employees | 71,000higher | 721lower |
| Total assets | $18.4Bhigher | $5.7Blower |
| Valuation | ||
| P/E | 30.2 | — |
| P/S | 2.1lower | 3396higher |
| P/B | 3.4 | — |
| Dividend yield | 0.77% | — |
| Profitability | ||
| Operating margin | 9.92%higher | -6236%lower |
| Balance sheet | ||
| Net assets | $8.6Bhigher | $4.5Blower |
| Total liabilities | $9.8Bhigher | $416.3Mlower |
| Total debt | $5.6B | — |
| Cash on hand | $532.3Mlower | $1.4Bhigher |
| Price change | ||
| Today | -1.13%lower | +0.26%higher |
| 1 year | +43.4%lower | +88.2%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Labcorp Holdings only (7)
- Wallace Weitz2.0%
- Diamond Hill team1.5%
- John Rogers1.0%
- Mark Boyar0.7%
- Charles Brandes (founder)0.5%
- Jensen team0.1%
- Mairs & Power team<0.1%
Roivant Sciences only (6)
- Andrew Spokes4.1%
- David Einhorn1.9%
- Lee Ainslie0.9%
- Julian and Felix Baker0.8%
- Andreas Halvorsen0.6%
- Steve Cohen0.2%
Percentages are each holding's share of that investor's reported portfolio. Who owns LH · Who owns ROIV
More on Labcorp Holdings
Further comparisons
Labcorp Holdings against its closest peers
Roivant Sciences against its closest peers
Learn
Questions and answers
Which is bigger, Labcorp Holdings or Roivant Sciences?
By market value, Labcorp Holdings is the larger: $29.9B against $28B for Roivant Sciences. By revenue in its latest fiscal year, Labcorp Holdings is the larger: $14B against $8.3M for Roivant Sciences.
Which has the higher operating margin?
Labcorp Holdings: 9.92%, against -6236% for Roivant Sciences. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which superinvestors own both Labcorp Holdings and Roivant Sciences?
None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Labcorp Holdings and 6 hold Roivant Sciences.
Cite this page
Funkfolio, “Labcorp Holdings vs Roivant Sciences”, data as of 18 November 2026. https://funkfolio.com/compare/lh-vs-roiv
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.